Literature DB >> 28508932

Enterovirus-Related Immune Reconstitution Inflammatory Syndrome (IRIS) Following Haploidentical Stem Cell Transplantation in an MHC Class II-Deficient Child.

Ravi M Shah1, Sheila Waugh2, Khuen F Ng3, Andrew R Gennery4, Mary Slatter4, Andrew J Cant3.   

Abstract

Entities:  

Keywords:  Enterovirus; Hematopoietic stem cell transplantation; Immune reconstitution inflammatory syndrome; TCRαβCD3+

Mesh：

Substances：

Year:  2017        PMID： 28508932     DOI： 10.1007/s10875-017-0402-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  7 in total

1.  Outcome of hematopoietic stem cell transplantation in severe combined immune deficiency with central nervous system viral infection.

Authors:  Cathy Waruiru; Mary A Slatter; Clive Taylor; Venkateswaran Ramesh; Terence J Flood; Mario Abinun; Andrew J Cant; Andrew R Gennery
Journal:  Pediatr Infect Dis J       Date:  2007-02       Impact factor: 2.129

Review 2.  Immune reconstitution syndrome associated with opportunistic mycoses.

Authors:  Nina Singh; John R Perfect
Journal:  Lancet Infect Dis       Date:  2007-06       Impact factor: 25.071

3.  Treatment of potentially life-threatening enterovirus infections with pleconaril.

Authors:  H A Rotbart; A D Webster
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

4.  Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome.

Authors:  Lis R V Antonelli; Yolanda Mahnke; Jessica N Hodge; Brian O Porter; Daniel L Barber; Rebecca DerSimonian; Jamieson H Greenwald; Gregg Roby; Joann Mican; Alan Sher; Mario Roederer; Irini Sereti
Journal:  Blood       Date:  2010-07-26       Impact factor: 22.113

5.  Enterovirus infections following T-cell depleted allogeneic transplants in adults.

Authors:  S Chakrabarti; H Osman; K E Collingham; C D Fegan; D W Milligan
Journal:  Bone Marrow Transplant       Date:  2004-02       Impact factor: 5.483

6.  High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.

Authors:  Nadia Driss; Imen Ben-Mustapha; Fethi Mellouli; Ahlem Ben Yahia; Henda Touzi; Mohamed Bejaoui; Mohamed Ben Ghorbel; Henda Triki; Mohamed-Ridha Barbouche
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

7.  Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

Authors:  Hsin-Yun Sun; Barbara D Alexander; Shirish Huprikar; Graeme N Forrest; Didier Bruno; G Marshall Lyon; Dannah Wray; Leonard B Johnson; Costi D Sifri; Raymund R Razonable; Michele I Morris; Valentina Stosor; Marilyn M Wagener; Nina Singh
Journal:  Clin Infect Dis       Date:  2014-09-09       Impact factor: 9.079
  7 in total
  3 in total

1.  Immune Reconstitution Inflammatory Syndrome as a Posttransplantation Complication in Primary Immunodeficiency With Disseminated Mycobacterium avium.

Authors:  Maura Manion; Dimana Dimitrova; Luxin Pei; Juan Gea-Banacloche; Adrian Zelazny; Andrea Lisco; Christa Zerbe; Alexandra F Freeman; Steven M Holland; Christopher G Kanakry; Jennifer A Kanakry; Irini Sereti
Journal:  Clin Infect Dis       Date:  2020-02-03       Impact factor: 9.079

2.  Case Report: Severe Acute Pulmonary COVID-19 in a Teenager Post Autologous Hematopoietic Stem Cell Transplant.

Authors:  Fabian J S van der Velden; Frederik van Delft; Stephen Owens; Judit Llevadias; Michael McKean; Lindsey Pulford; Yusri Taha; Grace Williamson; Quentin Campbell-Hewson; Sophie Hambleton; Rebecca Payne; Christopher Duncan; Catriona Johnston; Jarmila Spegarova; Marieke Emonts
Journal:  Front Pediatr       Date:  2022-03-03       Impact factor: 3.418

3.  Case Report: Immune reconstitution inflammatory syndrome after hematopoietic stem cell transplantation for severe combined immunodeficiency.

Authors:  Shuangjun Liu; Feng Huo; Guorui Dai; Jie Wu; Maoquan Qin; Huawei Mao; Quan Wang
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.